Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

StemCells Inc (NASDAQ:STEM)

Monday’s trading has closed, but STEM is being traded in the after-hours session. After-Hours quote »
0.3239
Delayed Data
As of 3:56pm ET
 -0.0061 / -1.85%
Today’s Change
0.29
Today|||52-Week Range
1.39
-22.23%
Year-to-Date
No recent news for StemCells Inc.

Today’s Trading

Previous close0.33
Today’s open0.34
Day’s range0.30 - 0.34
Volume400,606
Average volume (3 months)718,363
Market cap$35.9M
Dividend yield--
Data as of 3:56pm ET, 02/08/2016

Growth & Valuation

Earnings growth (last year)+13.18%
Earnings growth (this year)+29.50%
Earnings growth (next 5 years)+1.00%
Revenue growth (last year)-15.86%
P/E ratioNM
Price/Sales57.15
Price/Book3.86

Competitors

 Today’s
change
Today’s
% change
BINDBIND Therapeutics In...-0.27-16.36%
BPMXBioPharmX Corp+0.05+3.14%
APTOAptose Biosciences I...-0.13-4.71%
HSGXHistogenics Corp+0.09+3.72%
Data as of 4:02pm ET, 02/08/2016

Financials

Next reporting dateMarch 8, 2016
EPS forecast (this quarter)-$0.09
Annual revenue (last year)$1.0M
Annual profit (last year)-$32.6M
Net profit margin-3,186.58%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Ian John Massey
Chief Financial Officer &
Executive Vice President
Gregory T. Schiffman
Corporate headquarters
Newark, California

Forecasts

Partner Offers